Gentian Diagnostics
Less than 1K followers
GENT
Oslo Børs
Medical Equipment & Services
Health Care
Overview
Investor consensus
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analysers. Gentian’s expertise and focus lies within homogenous immunoassays, specifically infections, inflammations, kidney failures and congestive heart failures. The company headquarters and production facilities are located in Moss, Norway, serving the global human and veterinary diagnostics markets through sales and representative offices in key countries.
Read moreMarket cap
-
Turnover
-
Revenue
152.07M
EBIT %
10.34 %
P/E
-
Dividend yield-%
-
Financial calendar
6/5
2025
General meeting '25
7/5
2025
Interim report Q1'25
7/5
2025
Annual dividend
All
Press releases
ShowingAll content types
GENT: Mandatory notification of trade
GENT: Gentian Diagnostics strengthens commercial capabilities with key appointments
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools